Rozlytrek (entrectinib)

pCPA File Number: 21461
Negotiation Status:
Active Negotiation
Indication(s):
ROS1-positive Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
HOFFMANN-LA ROCHE LIMITED
CADTH Project Number:
PC0206
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable